FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and aims at treating patients with renal dysfunction. There are described a method for nephroprotection and a method for blood serum creatinine reduction in a mammal in need thereof. At least one compound described by the formula 
Y=O, NH, or at least one compound described by the formula 
, or a combination thereof, wherein R1 means a linear or branched, saturated or unsaturated C7-C11 alkyl group; A and B independently represents hydrogen or 
, and X represents a hydroxyl group, oxy anion with one- or two-valent metal counter-ions or an alkoxy group with a linear or branched C1-C4 alkyl residue is introduced into the mammal.
EFFECT: using the declared group of inventions is effective in treating the patients with renal dysfunction caused by fibrosis, and for reducing creatinine.
18 cl, 14 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS FOR ELEVATING AND SUSTAINING KETOSIS | 2014 |
|
RU2659386C2 |
| OPHTHALMOLOGICAL COMPOSITIONS | 2017 |
|
RU2756758C2 |
| METHOD OF PRODUCING TRIGLYCERIDES OF MEDIUM-CHAIN FATTY ACIDS | 2013 |
|
RU2641307C2 |
| ANTAGONISTS NEUROKININ-1 COMPOSITIONS FOR INTRAVENOUS INTRODUCTION | 2010 |
|
RU2642234C2 |
| METHODS FOR PRESERVING RENAL FUNCTION WITH USING XANTHINE OXIDOREDUCTASE | 2007 |
|
RU2508099C2 |
| METHOD FOR TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS | 2017 |
|
RU2765737C2 |
| USE OF 2-METHYLENE-19-NOR-(20S)-1α,25-DIHYDROXYVITAMIN D3 TO TREAT SECONDARY HYPERPARATHYROIDISM | 2013 |
|
RU2666995C2 |
| METHOD OF PROPHYLAXIS OF NEPHROTOXICITY INDUCED BY CYCLOSPORINE OR TACROLIMUS | 1998 |
|
RU2191020C2 |
| SEMIFLUOROCARBON COMPOUND CONTAINING CONTRAST AGENT | 2014 |
|
RU2672588C2 |
| APPLICATION OF VASOPEPTIDASE INHIBITORS IN PATIENTS WITH NEPHROPATHY | 2003 |
|
RU2336080C2 |
